Literature DB >> 16273787

Radiographic progression in rheumatoid arthritis.

Robert Landewé1, Désirée van der Heijde.   

Abstract

Radiographic progression is an important outcome measure in clinical trials and observational studies with patients with rheuamtoid arthritis. In this article we describe several aspects of measuring radiographic progression. We introduce the scoring method, discuss scoring methodology and issues regarding reliability of scoring, describe the relation between disease activity, radiographic progression and physical function, and introduce the concept of repair, a novelty in the field of measuring structural changes in RA.

Entities:  

Mesh：

Year:  2005        PMID： 16273787

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  7 in total

1.  Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study.

Authors:  Katherine P Liao; Michael E Weinblatt; Jing Cui; Christine Iannaccone; Lori B Chibnik; Bing Lu; Jonathan S Coblyn; Nancy A Shadick; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2011-03-29       Impact factor: 7.580

2.  A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions.

Authors:  Wan Yu Png; Yu Heng Kwan; Ka Keat Lim; Eng Hui Chew; Nai Lee Lui; Chuen Seng Tan; Truls Østbye; Julian Thumboo; Warren Fong
Journal:  Eur J Hosp Pharm       Date:  2018-05-02

3.  Serum Pyridinoline is Associated With Radiographic Joint Erosions in Rheumatoid Arthritis.

Authors:  Abu Mansor Matardiah Nor Hashimah; Rajalingham Sakthiswary; Syahrul Sazliyana Shaharir; Asrul Wahab
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

Review 4.  Certolizumab in the long-term treatment of rheumatoid arthritis.

Authors:  Abdul Khan; David L Scott
Journal:  Open Access Rheumatol       Date:  2011-08-25

Review 5.  Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research.

Authors:  Désirée van der Heijde; Dafna D Gladman; Arthur Kavanaugh; Philip J Mease
Journal:  Arthritis Res Ther       Date:  2020-02-03       Impact factor: 5.156

6.  Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.

Authors:  Nik-Madihah Nik-Azis; Nurulhuda Mohd; Fazalina Mohd Fadzilah; Nor Hazla Mohamed Haflah; Mohd Shahrir Mohamed Said; Badiah Baharin
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

7.  PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.

Authors:  Taku Suzuki; Katsunori Ikari; Koichiro Yano; Eisuke Inoue; Yoshiaki Toyama; Atsuo Taniguchi; Hisashi Yamanaka; Shigeki Momohara
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.